Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Prostate cancer

Is active surveillance safe for obese patients?

Nature Reviews Urology volume 11, pages 489–490 (2014)Cite this article

Subjects

Studies suggest that there is a link between obesity and a reduced risk of low-risk cancers, but an increased risk of high-grade, lethal disease. A recent paper has attempted to further define this risk, and causes us to question whether active surveillance is an appropriate treatment option for obese patients.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Allott, E. H., Masko, E. M. & Freedland, S. J. Obesity and prostate cancer: weighing the evidence. Eur. Urol. 63, 800–809 (2013).

    Article  CAS  PubMed  Google Scholar 

  2. Cao, Y. & Ma, J. Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis. Cancer Prev. Res. (Phila.) 4, 486–501 (2011).

    Article  CAS  PubMed  Google Scholar 

  3. Ma, J. et al. Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis. Lancet Oncol. 9, 1039–1047 (2008).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Bhindi, B. et al. Obesity Is Associated with Risk of Progression for Low-risk Prostate Cancers Managed Expectantly. Eur. Urol. http://dx.doi:10.1016/j.eururo.2014.06.005.

  5. Ho, T. et al. Obesity, prostate-specific antigen nadir, and biochemical recurrence after radical prostatectomy: biology or technique? Results from the SEARCH database. Eur. Urol. 62, 910–916 (2012).

    Article  PubMed  PubMed Central  Google Scholar 

  6. Chalfin, H. J. et al. Obesity and Long-Term Survival after Radical Prostatectomy. J. Urol. http://dx.doi:10.1016/j.juro.2014.04.086.

  7. Wolin, K. Y., Luly, J., Sutcliffe, S., Andriole, G. L. & Kibel, A. S. Risk of urinary incontinence following prostatectomy: the role of physical activity and obesity. J. Urol. 183, 629–633 (2010).

    Article  PubMed  Google Scholar 

  8. Mukherjee, P. et al. Energy intake and prostate tumor growth, angiogenesis, and vascular endothelial growth factor expression. J. Natl Cancer Inst. 91, 512–523 (1999).

    Article  CAS  PubMed  Google Scholar 

  9. Joshu, C. E. et al. Weight gain is associated with an increased risk of prostate cancer recurrence after prostatectomy in the PSA era. Cancer Prev. Res. (Phila.) 4, 544–551 (2011).

    Article  PubMed  Google Scholar 

  10. Epstein, M. M., Edgren, G., Rider, J. R., Mucci, L. A. & Adami, H. O. Temporal trends in cause of death among Swedish and US men with prostate cancer. J. Natl Cancer Inst. 104, 1335–1342 (2012).

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors wish to thank Dr Philip Kantoff from the Dana Farber Cancer Institute for his input into the content and writing of this review.

Author information

Authors and Affiliations

  1. Duke University, 571 Research Drive, MSRB 475, Durham, 27710, NC, USA

    Stephen Freedland

  2. Harvard School of Public Health, 677 Huntington Avenue, 9th Floor, Boston, 02115, MA, USA

    Lorelei Mucci

Authors
  1. Stephen Freedland
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lorelei Mucci
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stephen Freedland.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Freedland, S., Mucci, L. Is active surveillance safe for obese patients?. Nat Rev Urol 11, 489–490 (2014). https://doi.org/10.1038/nrurol.2014.207

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrurol.2014.207

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing